Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0024530 (
malaria
)
44,886
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We have previously demonstrated that invasion of erythrocytes (RBCs) by
malaria
merozoites follows a sequence: recognition and attachment in an apical orientation associated with widespread deformation of the RBC, junction formation, movement of the junction around the merozoite that brings the merozoite into the invaginated RBC membrane, and sealing of the membrane. In the present paper, we describe a method for blocking invasion at an early stage in the sequence. Cytochalasin-treated merozoites attach specifically to host RBCs, most frequently by the apical region that contains specialized organelles (rhoptries) associated with invasion. The parasite then forms a junction between the apical region and the RBC. Cytochalasin blocks movement of this junction, a later step in invasion. Cytochalasin-treated (Plasmodium knowlesi) merozoites attach to
Duffy
-negative human RBCs, although these RBCs are resistant to invasion by the parasite. The attachment with these RBCs, however, differs from susceptible RBCs in that there is no junction formation. Therefore the
Duffy
associated antigen appears to be involved in junction formation, not initial attachment.
...
PMID:Interaction between cytochalasin B-treated malarial parasites and erythrocytes. Attachment and junction formation. 10 74
To test the hypothesis that the Duffy blood group negative genotype is a factor in resistance to Plasmodium vivax, we determined the Duffy blood group, the
malaria
antibodies, and the slide-demonstrated infection rates with P. vivax and P. falciparum of 420 persons living in Nueva Armenia, Honduras. In all, 247 persons were
Duffy
negative. Demonstrated infections with P. falciparum were almost equally distributed between
Duffy
-positive (5,8%) and
Duffy
-negative (4.9%) persons. Similarly,
Duffy
-positive (25.6%) and
Duffy
-negative (28.2%) persons had equal proportions of indirect fluorescent antibody test titers suggestive of past or present P. falciparum infection. In contrast, all 14 P. vivax infections were found in
Duffy
-negative persons. There was no evidence suggesting that
Duffy
-positive and
Duffy
-negative persons had different exposures to
malaria
. The
Duffy
negative genotype FyFy appears to be a factor in resistance to P. vivax.
...
PMID:The Duffy blood group and resistance to Plasmodium vivax in Honduras. 35 34
Blood groups are an obstacle to reproduction, transfusion and transplantation. There are immunological abortions due to the antibodies of "p" phenotype women; and Rh haemolytic disease of the new-born is in direct proportion to the frequency of the "r" gene in a given population; the problem of transfusional allo-immunisation is completely parallel. Certain membrane anomalies (due to exceptional erythrocyte blood groups--Rh null, Rh mod or McLeod, for example), can provoke hemolytic anaemias, but in these cases the subjects are scattered throughout the world. An important problem is that of the relationships between
Duffy
antigens and
malaria
: from what is known about plasmodium Knowlesi, Fya and Fyb antigens are related to the erythrocyte receptors for this plasmodium: the Fy(a-b-) red cells, even of exceptional non-blacks, are not infested with parasites. Two kinds of receptors are postulated: one for adherence and another for penetration. In contrast, plasmodium falciparum does not recognise the same receptors as plasmodium Knowlesi. Experiments carried out on man have led to the conclusion that plasmodium vivax also used Fya and Fyb antigens to penetrate the red cell. These recent facts give rise to the problem of a possible natural selection by plasmodium vivax, which would eradicate polymorphism, whilst until now, the facts concerning plasmodium falciparum have explained the balance of polymorphism.
...
PMID:[Erythrocyte blood groups and geographic pathology (author's transl)]. 40 37
Data on a sample of 809 Afro-Americans indicated that there is no association between
Duffy
null (a-,b-) blood type and sickle cell trait. The results further rule out close linkage as an alternative hypothesis to explain the reported association between these loci in areas where falciparum and vivax
malaria
are endemic and indicate that, even if the two loci are independent or loosely linked, direct evidence of the selection favoring AS Fy-Fy- individuals must come from populations where mixed
malaria
infections occur. Stratification, as an explanation for the reported association, is also discussed.
...
PMID:Duffy blood group and hemoglobin variants. 59 38
Duffy
-blood-group-negative human erythrocytes, FyFy, are resistant to invasion in vitro by Plasmodium knowlesi. The FyFy genotype is found predominantly in African and American blacks, who are the only groups completely resistant to infection by P. vivax. To determine if the FyFy genotype is the vivax resistance factor, we performed blood typing on 11 black and six white volunteers who had been exposed to the bites of P. vivax-infected mosquitoes. Only the five FyFy blacks were resistant to erythrocytic infection; the remaining six blacks and all whites had the
Duffy
-positive determinants (Fya or Fyb or both) and had contracted
malaria
. We conclude that
Duffy
determinants (Fya or Fyb or both) on the erythrocyte surface are required for invasion of erythrocytes by vivax merozoites.
...
PMID:The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. 77 16
Duffy blood group negative human erythrocytes (FyFy) are resistant to infection by Plasmodium knowlesi, a simian
malaria
that infects
Duffy
positive human erythrocytes. The P. knowlesi resistance factor,
Duffy
negative erythrocytes, occurs in high frequency in West Africa, where the people are resistant to vivax
malaria
. This suggests that Duffy blood group determinants (Fya or Fyb) may be erythrocyte receptors for P. vivax.
...
PMID:Erythrocyte receptors for (Plasmodium knowlesi) malaria: Duffy blood group determinants. 114 13
Malaria
erythrocyte binding proteins use the Duffy blood group antigen (Plasmodium vivax and Plasmodium knowlesi) and sialic acid (Plasmodium falciparum) on the erythrocyte surface as receptors. We had previously cloned the one P. vivax gene, the one P. falciparum gene, and part of one of the three P. knowlesi genes encoding these erythrocyte binding proteins and described the homology between the P. knowlesi and P. vivax genes. We have completed the cloning and sequencing of the three P. knowlesi genes and identified introns in the P. vivax and P. falciparum genes that correct the previously published deduced amino acid sequences. All have similar structures, with one or two exons encoding the signal sequence and the erythrocyte binding domain, an exon encoding the transmembrane domain, and two exons encoding the cytoplasmic domain with the exception of the P. knowlesi beta gene. The regions of amino acid sequence homology among all the genes are the 5' and 3' cysteine-rich regions of the erythrocyte binding domain. On the basis of gene structure and amino acid homology, we propose that the
Duffy
binding proteins and the sialic acid binding protein are members of a gene family. The level of conservation (approximately 70%) of the deduced amino acid sequences in the 5' cysteine-rich region between the P. vivax protein and the three P. knowlesi proteins is as great as between the three P. knowlesi proteins themselves; the P. knowlesi beta protein just 3' to this cysteine-rich region is homologous to the P. vivax protein but not to the other P. knowlesi proteins. Conservation of amino acid sequences among these organisms, separated in evolution, may indicate the regions where the adhesin function resides.
...
PMID:A family of erythrocyte binding proteins of malaria parasites. 149 4
Blood samples from 324 malarial patients and 384 healthy individuals belonging to the Ao tribal community have been examined for Duffy blood group systems. The complete absence of
Duffy
-negative individuals among the Ao Nagas suggests that selection for resistance to vivax
malaria
by means of the
Duffy
-negative phenotype has not been available in the southeast Asian regions including the Ao Nagas.
...
PMID:Duffy blood groups and malaria in the Ao Nagas in Nagaland, India. 178 11
We have previously reported that the Tharu people of the Terai region in southern Nepal have an incidence of
malaria
about sevenfold lower than that of synpatric non-Tharu people. In order to find out whether this marked resistance against
malaria
has a genetic basis, we have now determined in these populations the prevalence of candidate protective genes and have performed in-vitro cultures of Plasmodium falciparum in both Tharu and non-Tharu red cells. We have found significant but relatively low and variable frequencies of beta-thal, beta S, G6PD (-), and
Duffy
(a-b-) in different parts of the Terai region. The average in-vitro rate of invasion and of parasite multiplication did not differ significantly in red cells from Tharus versus those from non-Tharu controls. By contrast, the frequency of alpha-thalassemia is uniformly high in Tharus, with the majority of them having the homozygous alpha-/alpha-genotype and an overall alpha-thal gene (alpha-) frequency of .8. We suggest that holoendemic
malaria
has caused preferential survival of subjects with alpha-thal and that this genetic factor has enabled the Tharus as a population to survive for centuries in a
malaria
-holoendemic area. From our data we estimate that the alpha-thal homozygous state decreases morbidity from
malaria
by about 10-fold. This is an example of selection evolution toward fixation of an otherwise abnormal gene.
...
PMID:Protection against malaria morbidity: near-fixation of the alpha-thalassemia gene in a Nepalese population. 199 Aug 45
A short-term in vitro culture system that allows for significant re-invasion of target erythrocytes by Plasmodium vivax was used to study the role of the Duffy blood group antigen as a ligand for merozoite invasion by this human
malaria
species. Using human
Duffy
-positive and -negative erythrocytes, various primate erythrocytes, enzymatic modification of erythrocytes, and mAb that defines a new
Duffy
determinant (Fy6) we conclude that the erythrocyte glycoprotein carrying
Duffy
determinants is required as a ligand for the invasion of human erythrocytes by P. vivax merozoites. Blockade of invasion by Fab fragments of the anti-Fy6 mAb equal to that of the intact molecule and the correlation of P. vivax susceptibility with the presence of the Fy6 determinant suggests this epitope or a nearby domain may be an active site on the
Duffy
glycoprotein. However, as for P. knowlesi, there is evidence that an alternate pathway for P. vivax invasion of simian erythrocytes may exist.
...
PMID:In vitro evaluation of the role of the Duffy blood group in erythrocyte invasion by Plasmodium vivax. 246 69
1
2
3
4
5
6
7
8
9
10
Next >>